BRCA1, familial breast-ovarian cancer susceptibility 1

Treatment

Should men with a BRCA1 mutation have prostate cancer screening?

Prostate cancer screening is recommended for men who carry a BRCA1 mutation. Prostate cancer screening may be recommended to begin around age 40 for men with a BRCA1 gene mutation, which is a younger age than the screening recommendation for men in the general population. Men with a BRCA1 gene mutation should talk with their doctor about current screening guidelines.

SOURCE: Emory University - Department of Human Genetics in collaboration with ThinkGenetic • https://www.thinkgenetic.com/diseases/brca1-familial-breast-ovarian-cancer-susceptibility-1/treatment/17670 • DATE UPDATED: 2019-07-09

References

National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast and Ovarian (Version 2.2016). https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me